Buprenorphine: A potential new treatment option for opioid dependence

CMAJ. Canadian Medical Association Journal

Volumn 174, Issue 13, 2006, Pages 1835-1836

  Srivastava, Anita ^a   Kahan, Meldon ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; CLONIDINE; CYTOCHROME P450 3A4; METHADONE; MU OPIATE RECEPTOR; OPIATE; OXYCODONE;

ANALGESIA; CONSTIPATION; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EUPHORIA; HUMAN; NAUSEA; OPIATE ADDICTION; RESPIRATION DEPRESSION; SEDATION; SHORT SURVEY; TABLET FORMULATION; VOMITING;

EID: 33745676317     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.050658     Document Type: Short Survey

References (5)

1. Fischer B, J Rehm. The case for a heroin substitution treatment trial in Canada. Can J Public Health 1997;88:367-70.
2. Fischer B, Chin AT, Kuo I, et al. Canadian illicit opiate users' views on methadone and other opiate prescription treatment: an exploratory qualitative study. Subst Use Misuse 2002;37:495-522.
3. Mattick, RP, Kimber J, Breen C, et al. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. [Cochrane review]. In: the Cochrane Library; Issue 2, 2003. Oxford: Update Software.
4. Vignau I, Brunelle E. Differences between general practitioner- and addiction centre-prescribed buprenorphine substitution therapy in France. Preliminary results. Eur Addict Res 1998;4(Suppl 1): 24-8.
5. Doran CM, Shanahan M, Mattick RP, et al. Buprenorphine versus methadone maintenance: a cost-effectiveness analysis. Drug Alcohol Depend 2003; 71(3):295-302.